Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder

Abstract Oxytocin (OT) is a critical molecule for social recognition and memory that mediates social and emotional behaviours. In addition, OT acts as an anxiolytic factor and is released during stress. Based on the activity of CD38 as an enzyme that produces the calcium-mobilizing second messenger...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Gerasimenko, Stanislav M. Cherepanov, Kazumi Furuhara, Olga Lopatina, Alla B. Salmina, Anna A. Shabalova, Chiharu Tsuji, Shigeru Yokoyama, Katsuhiko Ishihara, Charles Brenner, Haruhiro Higashida
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e2c0923f4072493b8dda2df22fce9bb6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e2c0923f4072493b8dda2df22fce9bb6
record_format dspace
spelling oai:doaj.org-article:e2c0923f4072493b8dda2df22fce9bb62021-12-02T17:45:03ZNicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder10.1038/s41598-019-57236-72045-2322https://doaj.org/article/e2c0923f4072493b8dda2df22fce9bb62020-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-57236-7https://doaj.org/toc/2045-2322Abstract Oxytocin (OT) is a critical molecule for social recognition and memory that mediates social and emotional behaviours. In addition, OT acts as an anxiolytic factor and is released during stress. Based on the activity of CD38 as an enzyme that produces the calcium-mobilizing second messenger cyclic ADP-ribose (cADPR), CD157, a sister protein of CD38, has been considered a candidate mediator for the production and release of OT and its social engagement and anti-anxiety functions. However, the limited expression of CD157 in the adult mouse brain undermined confidence that CD157 is an authentic and/or actionable molecular participant in OT-dependent social behaviour. Here, we show that CD157 knockout mice have low levels of circulating OT in cerebrospinal fluid, which can be corrected by the oral administration of nicotinamide riboside, a recently discovered vitamin precursor of nicotinamide adenine dinucleotide (NAD). NAD is the substrate for the CD157- and CD38-dependent production of cADPR. Nicotinamide riboside corrects social deficits and fearful and anxiety-like behaviours in CD157 knockout males. These results suggest that elevating NAD levels with nicotinamide riboside may allow animals with cADPR- and OT-forming deficits to overcome these deficits and function more normally.Maria GerasimenkoStanislav M. CherepanovKazumi FuruharaOlga LopatinaAlla B. SalminaAnna A. ShabalovaChiharu TsujiShigeru YokoyamaKatsuhiko IshiharaCharles BrennerHaruhiro HigashidaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maria Gerasimenko
Stanislav M. Cherepanov
Kazumi Furuhara
Olga Lopatina
Alla B. Salmina
Anna A. Shabalova
Chiharu Tsuji
Shigeru Yokoyama
Katsuhiko Ishihara
Charles Brenner
Haruhiro Higashida
Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
description Abstract Oxytocin (OT) is a critical molecule for social recognition and memory that mediates social and emotional behaviours. In addition, OT acts as an anxiolytic factor and is released during stress. Based on the activity of CD38 as an enzyme that produces the calcium-mobilizing second messenger cyclic ADP-ribose (cADPR), CD157, a sister protein of CD38, has been considered a candidate mediator for the production and release of OT and its social engagement and anti-anxiety functions. However, the limited expression of CD157 in the adult mouse brain undermined confidence that CD157 is an authentic and/or actionable molecular participant in OT-dependent social behaviour. Here, we show that CD157 knockout mice have low levels of circulating OT in cerebrospinal fluid, which can be corrected by the oral administration of nicotinamide riboside, a recently discovered vitamin precursor of nicotinamide adenine dinucleotide (NAD). NAD is the substrate for the CD157- and CD38-dependent production of cADPR. Nicotinamide riboside corrects social deficits and fearful and anxiety-like behaviours in CD157 knockout males. These results suggest that elevating NAD levels with nicotinamide riboside may allow animals with cADPR- and OT-forming deficits to overcome these deficits and function more normally.
format article
author Maria Gerasimenko
Stanislav M. Cherepanov
Kazumi Furuhara
Olga Lopatina
Alla B. Salmina
Anna A. Shabalova
Chiharu Tsuji
Shigeru Yokoyama
Katsuhiko Ishihara
Charles Brenner
Haruhiro Higashida
author_facet Maria Gerasimenko
Stanislav M. Cherepanov
Kazumi Furuhara
Olga Lopatina
Alla B. Salmina
Anna A. Shabalova
Chiharu Tsuji
Shigeru Yokoyama
Katsuhiko Ishihara
Charles Brenner
Haruhiro Higashida
author_sort Maria Gerasimenko
title Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
title_short Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
title_full Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
title_fullStr Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
title_full_unstemmed Nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of CD157 mutants in a mouse model of autism spectrum disorder
title_sort nicotinamide riboside supplementation corrects deficits in oxytocin, sociability and anxiety of cd157 mutants in a mouse model of autism spectrum disorder
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/e2c0923f4072493b8dda2df22fce9bb6
work_keys_str_mv AT mariagerasimenko nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT stanislavmcherepanov nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT kazumifuruhara nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT olgalopatina nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT allabsalmina nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT annaashabalova nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT chiharutsuji nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT shigeruyokoyama nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT katsuhikoishihara nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT charlesbrenner nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
AT haruhirohigashida nicotinamideribosidesupplementationcorrectsdeficitsinoxytocinsociabilityandanxietyofcd157mutantsinamousemodelofautismspectrumdisorder
_version_ 1718379619292282880